De-Escalation Therapy for Human Papillomavirus Negative Disease
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- HNSCC
- HPV-Related Squamous Cell Carcinoma
- Human Papilloma Virus
- Squamous Cell Carcinoma
- Squamous Cell Carcinoma of the Head and Neck
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: Non-RandomizedIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03944915
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Everett Vokes, MD University of Chicago
Get Well Soon